Robert Fried

Robert Fried

Chief Executive OfficeratNiagen Bioscience· In proxies 2021–2025

Pay in FY2025+592% from the year before · Niagen Bioscience stock +19.9% the same year

Robert Fried was paid $8.4M in FY2025 (Dec), up 592%. Niagen Bioscience stock rose 19.9% that year.

Pay$100 in the stock at the end of FY20 → $133
Pay is from the Summary Compensation Table of each Niagen Bioscience proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Niagen BiosciencePublic company · 5 yr
    • Chief Executive Officer2021 – Present · 5 yrStock in role -49%
  2. Fluent, Inc.Public company · 4 yr
    • Director2011 – 2015 · 4 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?